Fractures are a common injury that can affect people of all ages. Supracondylar fractures are one of the most common fractures in children, occurring in the upper part of the distal humerus, just above the elbow joint. As the most common type of fracture in the elbow region, supracondylar fractures are a significant source of morbidity and disability in the pediatric population. The treatment of supracondylar fractures has traditionally been surgical, but there is now a new approach that is revolutionizing the way doctors treat this type of fracture.
In the past, the traditional treatment of supracondylar fractures has been to surgically reduce the fracture and fix it with a plate and screws. This method is effective, but it is also associated with a number of risks and complications. These include infection, nerve injury, vascular injury, and joint stiffness. In addition, the surgery is invasive and can be painful for the patient. It also requires a long recovery period, with the patient having to wear a cast for several weeks or even months.
The new approach to treating supracondylar fractures is a minimally invasive technique called percutaneous pinning. This technique involves inserting small pins through the skin and into the bone to stabilize the fracture. The pins are then connected to a frame that is secured to the bone with screws. This frame acts as an external splint, holding the fracture in place while it heals. The advantages of this technique over traditional surgery are numerous. First, it is much less invasive, with no need for open surgery or a cast. This means that the patient experiences less pain and has a much shorter recovery time. In addition, the risk of infection and other complications is greatly reduced. Finally, the percutaneous pinning technique is much more cost-effective than traditional surgery.
The new percutaneous pinning technique is revolutionizing the way doctors treat supracondylar fractures. It is a much less invasive procedure than traditional surgery, with fewer risks and complications, a shorter recovery time, and a lower cost. This technique is already being used with great success in the treatment of supracondylar fractures, and it is likely to become the standard of care in the near future.
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation